ASX - Delayed Quote
AUD
Australian Clinical Labs Limited (ACL.AX)
3.2250
-0.0750
(-2.27%)
As of 2:24:18 PM GMT+11. Market Open.
Loading chart for ACL.AX
- Previous Close
3.3000 - Open
3.3100 - Bid 3.2200 x --
- Ask 3.2300 x --
- Day's Range
3.0600 - 3.3200 - 52 Week Range
1.8325 - 3.3200 - Volume
1,423,188 - Avg. Volume
663,242 - Market Cap (intraday)
601.524M - Beta (5Y Monthly) 0.82
- PE Ratio (TTM)
26.88 - EPS (TTM)
0.1200 - Earnings Date (est.) --
- Forward Dividend & Yield 0.13 (3.94%)
- Ex-Dividend Date Sep 2, 2026
- 1y Target Est
2.95
Recent News
View MorePerformance Overview
Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
ACL.AX
23.42%
S&P/ASX 200 [XJO] (^AXJO)
1.54%
1-Year Return
ACL.AX
29.05%
S&P/ASX 200 [XJO] (^AXJO)
0.52%
3-Year Return
ACL.AX
38.59%
S&P/ASX 200 [XJO] (^AXJO)
26.80%
5-Year Return
ACL.AX
4.32%
S&P/ASX 200 [XJO] (^AXJO)
19.69%
Analyst Insights
View MoreStatistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (current)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
3.22%
-
Return on Assets (ttm)
7.45%
-
Return on Equity (ttm)
14.93%
-
Revenue (ttm)
736.15M
-
Net Income Avi to Common (ttm)
23.71M
-
Diluted EPS (ttm)
0.1200
Balance Sheet and Cash Flow
-
Total Cash (mrq)
25.66M
-
Total Debt/Equity (mrq)
225.31%
-
Levered Free Cash Flow (ttm)
166.66M
